Intervention

Treprostinil

ClinicalTrials.gov intervention label

Clinical trials10
Recruiting1
Common conditions8
Lead sponsors shown9

Clinical trials

10 shown
Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)NCT07837830 · 2026-09-01
RECRUITING
Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial HypertensionNCT07177703 · 2025-10-31
NOT_YET_RECRUITING
A Study to Observe the Safety, Tolerability, and Efficacy of RemodulinNCT06603285 · 2025-10-16
NOT_YET_RECRUITING
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary HypertensionNCT05564637 · 2023-03-13
COMPLETED
A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes MellitusNCT05067270 · 2021-10-22
COMPLETED
Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial HypertensionNCT03835676 · 2019-05-01
UNKNOWN
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAHNCT03888365 · 2019-04-01
COMPLETED
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary HypertensionNCT01028651 · 2011-01-01
COMPLETED
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin MedicationNCT01268553 · 2010-08-01
COMPLETED
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial HypertensionNCT00705133 · 2008-07-01
COMPLETED

Trial status mix

COMPLETED6
NOT_YET_RECRUITING2
RECRUITING1
UNKNOWN1

Phase mix

PHASE23
PHASE42
EARLY_PHASE11
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.